PROG's logo.
Ticker Symbol: PROG

Progenity Inc

$4.84 - 20-11-2024 4 p.m. ET

Exchange: NASDAQ Country: US Currency: USD Asset Type: Common Stock CIK:0001580063

Company Profile

Progenity, Inc. is a biotechnology company with an established track record of success in developing and commercializing molecular testing products, as well as innovating in the field of precision medicine. Progenity provides in vitro molecular tests designed to improve lives by providing actionable information that helps guide patients and physicians in making medical decisions during key life stages. The company applies a multi-omics approach, combining genomics, epigenomics, proteomics, and metabolomics to its molecular testing products and to the development of a suite of investigational ingestible devices designed to provide precise diagnostic sampling and drug delivery solutions. Progenity’s vision is to transform healthcare to become more precise and personal by improving diagnoses of disease and improving patient outcomes through localized treatment with targeted therapies.

Sector: Health Care and Social Assistance
Industry: Medical Laboratories
Standard Industrial Classification Code (SIC code): 8071
Address: 4330 La Jolla Village Dr Ste 200
CEO: Harry Stylli
Tags:
  • Health Services
  • Medical/Nursing Services
  • Health Care and Social Assistance
  • Medical Laboratories

Pricing

Last Updated: April 1, 2022 03:00 PM EST
Previous Close: $1.13
Change: -$0.02 ( -1.72%)
Days Range: $1.12 - $1.21
Beta: 1.42
52wk. High: $6.20
52wk. Low: $0.65
Ytd. Change -47.18%
50 Day Moving Average: $1.39
200 Day Moving Average: $2.09
Shares Outstanding: 184125819

Valuation

Market Cap: 21.0B
PE Ratio: -
EPS (TTM): 0

Dividends

Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A